• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经皮冠状动脉介入治疗:良好实践与培训建议

Percutaneous coronary intervention: recommendations for good practice and training.

作者信息

Dawkins K D, Gershlick T, de Belder M, Chauhan A, Venn G, Schofield P, Smith D, Watkins J, Gray H H

机构信息

British Cardiovascular Intervention Society, London, UK.

出版信息

Heart. 2005 Dec;91 Suppl 6(Suppl 6):vi1-27. doi: 10.1136/hrt.2005.061457.

DOI:10.1136/hrt.2005.061457
PMID:16365340
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1876395/
Abstract

Cardiologists undertaking percutaneous coronary intervention (PCI) are excited by the combination of patient and physician satisfaction and technological advance occurring on the background of the necessary manual dexterity. Progress and applicability of percutaneous techniques since their inception in 1977 have been remarkable; a sound evidence base coupled with the enthusiasm and ingenuity of the medical device industry has resulted in a sea change in the treatment of coronary heart disease (CHD), which continues to evolve at breakneck speed. This is the third set of guidelines produced by the British Cardiovascular Intervention Society and the British Cardiac Society. Following the last set of guidelines published in 2000, we have seen PCI activity in the UK increase from 33,652 to 62,780 (87% in four years) such that the PCI to coronary artery bypass grafting ratio has increased to 2.5:1. The impact of drug eluting stents has been profound, and the Department of Health is investigating the feasibility of primary PCI for acute myocardial infarction. Nevertheless, the changes in the structure of National Health Service funding are likely to focus our attention on cost effective treatments and will require physician engagement and sensitive handling if we are to continue the rapid and appropriate growth in our chosen field. It is important with this burgeoning development now occurring on a broad front (in both regional centres and district general hospitals) that we maintain our vigilance on audit and outcome measures so that standards are maintained for both operators and institutions alike. This set of guidelines includes new sections on training, informed consent, and a core evidence base, which we hope you will find useful and informative.

摘要

进行经皮冠状动脉介入治疗(PCI)的心脏病专家,对患者满意度、医生满意度以及在必要的手工操作技能背景下出现的技术进步这三者的结合感到兴奋。自1977年经皮技术问世以来,其进展和适用性令人瞩目;坚实的证据基础,再加上医疗设备行业的热情与创造力,已使冠心病(CHD)的治疗发生了翻天覆地的变化,且这种变化仍在以惊人的速度持续发展。这是英国心血管介入学会和英国心脏学会制定的第三套指南。自2000年发布上一套指南以来,我们看到英国的PCI手术量从33,652例增加到了62,780例(四年内增长了87%),使得PCI与冠状动脉旁路移植术的比例增至2.5:1。药物洗脱支架的影响深远,卫生部正在研究急性心肌梗死进行直接PCI的可行性。然而,国民医疗服务体系资金结构的变化可能会使我们将注意力集中在具有成本效益的治疗方法上,并且如果我们要在所选领域继续实现快速且恰当的发展,就需要医生的参与以及谨慎的应对措施。鉴于目前在广泛领域(包括区域中心和地区综合医院)都出现了这种蓬勃发展的情况,我们必须对审核和结果指标保持警惕,以便为操作者和机构维持标准。这套指南包括关于培训、知情同意和核心证据基础的新章节,我们希望您会发现它们有用且信息丰富。

相似文献

1
Percutaneous coronary intervention: recommendations for good practice and training.经皮冠状动脉介入治疗:良好实践与培训建议
Heart. 2005 Dec;91 Suppl 6(Suppl 6):vi1-27. doi: 10.1136/hrt.2005.061457.
2
API expert consensus document on management of ischemic heart disease.缺血性心脏病管理的API专家共识文件
J Assoc Physicians India. 2006 Jun;54:469-80.
3
[The European Society of Cardiology (ESC) guidelines for percutaneous coronary interventions (PCI). Three case reports].[欧洲心脏病学会(ESC)经皮冠状动脉介入治疗(PCI)指南。三例病例报告]
Herz. 2006 Dec;31(9):836-46, 848. doi: 10.1007/s00059-006-2939-y.
4
Emergency percutaneous coronary intervention (PCI) for the care of patients with ST-elevation myocardial infarction (STEMI).用于ST段抬高型心肌梗死(STEMI)患者治疗的急诊经皮冠状动脉介入治疗(PCI)。
Minerva Cardioangiol. 2007 Oct;55(5):593-623.
5
Outcomes of coronary artery bypass grafting versus percutaneous coronary intervention with drug-eluting stents for patients with multivessel coronary artery disease.多支冠状动脉疾病患者冠状动脉搭桥术与药物洗脱支架经皮冠状动脉介入治疗的疗效比较
Circulation. 2007 Sep 11;116(11 Suppl):I200-6. doi: 10.1161/CIRCULATIONAHA.106.681148.
6
Acute coronary care in the elderly, part I: Non-ST-segment-elevation acute coronary syndromes: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology.老年人急性冠脉护理,第一部分:非ST段抬高型急性冠脉综合征:美国心脏协会临床心脏病学委员会为医疗专业人员发布的科学声明:与老年心脏病学会合作制定
Circulation. 2007 May 15;115(19):2549-69. doi: 10.1161/CIRCULATIONAHA.107.182615.
7
Prospective multicenter randomized trial comparing physician versus patient transfer for primary percutaneous coronary intervention in acute ST-segment elevation myocardial infarction.一项前瞻性多中心随机试验,比较急性ST段抬高型心肌梗死患者在进行直接经皮冠状动脉介入治疗时由医生转运与由患者转运的情况。
Chin Med J (Engl). 2008 Mar 20;121(6):485-91.
8
Antiplatelet therapy in percutaneous coronary intervention: a critical review of the 2007 AHA/ACC/SCAI guidelines and beyond.经皮冠状动脉介入治疗中的抗血小板治疗:对2007年美国心脏协会/美国心脏病学会/心血管造影和介入学会指南及其他相关内容的批判性综述
Catheter Cardiovasc Interv. 2009 Oct 1;74(4):579-97. doi: 10.1002/ccd.22021.
9
Nonrandomized comparison of coronary artery bypass surgery and percutaneous coronary intervention for the treatment of unprotected left main coronary artery disease in octogenarians.八旬老人非保护左主干冠状动脉疾病治疗中冠状动脉搭桥手术与经皮冠状动脉介入治疗的非随机对照比较
Circulation. 2008 Dec 2;118(23):2374-81. doi: 10.1161/CIRCULATIONAHA.107.727099. Epub 2008 Nov 24.
10
For which patients with left main stem disease is percutaneous intervention rather than coronary artery bypass grafting the better option?对于哪些患有左主干疾病的患者来说,经皮介入治疗而非冠状动脉旁路移植术是更好的选择?
Interact Cardiovasc Thorac Surg. 2008 Apr;7(2):306-14. doi: 10.1510/icvts.2007.169938. Epub 2008 Jan 14.

引用本文的文献

1
Percutaneous Coronary Intervention in the UK: Recommendations of the British Cardiovascular Intervention Society.英国经皮冠状动脉介入治疗:英国心血管介入学会的建议
Interv Cardiol. 2025 Jan 23;20:e01. doi: 10.15420/icr.2024.43. eCollection 2025.
2
Outcomes of PCI of all comers: the experience of a Kuwaiti independent healthcare institution.所有患者的经皮冠状动脉介入治疗结果:一家科威特独立医疗机构的经验。
Br J Cardiol. 2024 Apr 16;31(2):016. doi: 10.5837/bjc.2024.016. eCollection 2024.
3
High-dose statin pretreatment decreases periprocedural myocardial infarction and cardiovascular events in East Asian patients undergoing percutaneous coronary intervention: A meta-analysis of fifteen randomized controlled trials.大剂量他汀类药物预处理可降低接受经皮冠状动脉介入治疗的东亚患者围手术期心肌梗死和心血管事件的发生率:一项对15项随机对照试验的荟萃分析。
Medicine (Baltimore). 2021 Jun 25;100(25):e26278. doi: 10.1097/MD.0000000000026278.
4
Is Hospital Percutaneous Coronary Intervention Volume-In-hospital Outcome Relation an Issue in Acute Myocardial Infarction?医院经皮冠状动脉介入治疗量与院内结局的关系在急性心肌梗死中是一个问题吗?
Korean Circ J. 2020 Nov;50(11):1037-1039. doi: 10.4070/kcj.2020.0383.
5
Impact of Hospital Volume of Percutaneous Coronary Intervention (PCI) on In-Hospital Outcomes in Patients with Acute Myocardial Infarction: Based on the 2014 Cohort of the Korean Percutaneous Coronary Intervention (K-PCI) Registry.经皮冠状动脉介入治疗(PCI)的医院手术量对急性心肌梗死患者院内结局的影响:基于2014年韩国经皮冠状动脉介入治疗(K-PCI)注册研究队列
Korean Circ J. 2020 Nov;50(11):1026-1036. doi: 10.4070/kcj.2020.0172.
6
Physician engagement: a concept analysis.医生参与度:一项概念分析
J Healthc Leadersh. 2019 Jul 26;11:101-113. doi: 10.2147/JHL.S214765. eCollection 2019.
7
Status of radiation protection in various interventional cardiology procedures in the Asia Pacific region.亚太地区各种介入心脏病学手术中的辐射防护状况。
Heart Asia. 2011 Jan 1;3(1):16-24. doi: 10.1136/ha.2009.001180. eCollection 2011.
8
Decision making on timing of surgery for hip fracture patients on clopidogrel.关于服用氯吡格雷的髋部骨折患者手术时机的决策
Ann R Coll Surg Engl. 2016 Feb;98(2):91-5. doi: 10.1308/rcsann.2015.0041.
9
Clopidogrel and Proximal Femoral Fractures: Does Timing of Surgery Affect Blood Loss and Length of Admission? A Preliminary Study Prior to Multicenter Trial.氯吡格雷与股骨近端骨折:手术时机是否会影响失血量和住院时间?一项多中心试验前的初步研究。
Eur J Trauma Emerg Surg. 2009 Jun;35(3):291. doi: 10.1007/s00068-008-8093-x. Epub 2008 Oct 22.
10
Access to specialist care: Optimizing the geographic configuration of trauma systems.获得专科护理:优化创伤系统的地理配置。
J Trauma Acute Care Surg. 2015 Nov;79(5):756-65. doi: 10.1097/TA.0000000000000827.

本文引用的文献

1
Inhibition of restenosis with a paclitaxel-eluting, polymer-free coronary stent: the European evaLUation of pacliTaxel Eluting Stent (ELUTES) trial.使用不含聚合物的紫杉醇洗脱冠状动脉支架抑制再狭窄:欧洲紫杉醇洗脱支架(ELUTES)试验评估
Circulation. 2004 Feb 3;109(4):487-93. doi: 10.1161/01.CIR.0000109694.58299.A0. Epub 2004 Jan 26.
2
A clinical trial of abciximab in elective percutaneous coronary intervention after pretreatment with clopidogrel.在氯吡格雷预处理后进行的阿昔单抗用于择期经皮冠状动脉介入治疗的临床试验。
N Engl J Med. 2004 Jan 15;350(3):232-8. doi: 10.1056/NEJMoa031859.
3
A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease.一种用于冠心病患者的基于聚合物的紫杉醇洗脱支架。
N Engl J Med. 2004 Jan 15;350(3):221-31. doi: 10.1056/NEJMoa032441.
4
Evaluation of patient-absorbed doses during coronary angiography and intervention by femoral and radial artery access.经股动脉和桡动脉途径进行冠状动脉造影及介入治疗时患者吸收剂量的评估。
Eur Radiol. 2004 Apr;14(4):653-8. doi: 10.1007/s00330-003-2120-4. Epub 2003 Nov 14.
5
Long term follow up after elective percutaneous coronary intervention for unprotected non-bifurcational left main stenosis: is it time to change the guidelines?非保护非分叉型左主干狭窄择期经皮冠状动脉介入治疗后的长期随访:是时候改变指南了吗?
Heart. 2003 Nov;89(11):1336-9. doi: 10.1136/heart.89.11.1336.
6
Effects of statins on platelet inhibition by a high loading dose of clopidogrel.他汀类药物对高负荷剂量氯吡格雷血小板抑制作用的影响。
Circulation. 2003 Nov 4;108(18):2195-7. doi: 10.1161/01.CIR.0000099507.32936.C0. Epub 2003 Oct 20.
7
Safety of same-day-discharge radial percutaneous coronary intervention: a retrospective study.当日出院经桡动脉冠状动脉介入治疗的安全性:一项回顾性研究。
Am Heart J. 2003 Oct;146(4):699-704. doi: 10.1016/S0002-8703(03)00258-8.
8
Combining enoxaparin and glycoprotein IIb/IIIa antagonists for the treatment of acute coronary syndromes: final results of the National Investigators Collaborating on Enoxaparin-3 (NICE-3) study.联合使用依诺肝素和糖蛋白IIb/IIIa拮抗剂治疗急性冠状动脉综合征:依诺肝素-3全国研究者协作研究(NICE-3)的最终结果
Am Heart J. 2003 Oct;146(4):628-34. doi: 10.1016/S0002-8703(03)00165-0.
9
Percutaneous coronary intervention for cardiogenic shock in the SHOCK trial.SHOCK试验中用于心源性休克的经皮冠状动脉介入治疗
J Am Coll Cardiol. 2003 Oct 15;42(8):1380-6. doi: 10.1016/s0735-1097(03)01050-7.
10
Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: double-blind, randomised controlled trial (E-SIRIUS).西罗莫司洗脱支架治疗小冠状动脉长动脉粥样硬化病变患者:双盲、随机对照试验(E-SIRIUS)
Lancet. 2003 Oct 4;362(9390):1093-9. doi: 10.1016/S0140-6736(03)14462-5.